STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Clinical trials for STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tighter blood pressure control may shield cancer patients from heart and kidney harm
Disease control OngoingThis study looks at whether keeping blood pressure very low (below 120 mmHg) is better than the usual target (below 140 mmHg) for people with advanced kidney or thyroid cancer starting certain targeted therapies. The goal is to reduce the risk of heart and kidney problems caused …
Matched conditions: STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Phase: NA • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New combo therapy shows promise for HIV patients with advanced cancer
Disease control OngoingThis early-phase trial is testing the safety of combining two cancer drugs—nivolumab and cabozantinib—in people with HIV who have advanced solid tumors. The study includes 8 participants with various cancers that have spread. The goal is to see if the combination can shrink or st…
Matched conditions: STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC